Introduction
When people experience persistent joint, muscle, or other musculoskeletal concerns, they may have questions about their treatment options, including whether non-surgical approaches should be considered before surgery.
Regenerative medicine is a broad area of healthcare that includes different biological and minimally invasive approaches being studied for a variety of medical conditions. Depending on the specific treatment and the individual’s circumstances, a healthcare professional may discuss regenerative medicine as one of several options to consider.
However, regenerative medicine is not appropriate for every condition or every patient. Treatment decisions should be based on an appropriate medical evaluation, the underlying cause of the symptoms, available evidence, potential risks, and the individual’s goals.
What Is Regenerative Medicine?
Regenerative medicine is a broad field focused on approaches that investigate how biological processes may be used in the context of tissue and musculoskeletal health.
The term can refer to different types of treatments and technologies, and these approaches should not be considered interchangeable. Examples discussed in medical research include platelet-rich plasma (PRP), certain cell-based therapies, tissue engineering, and other biological approaches.
The evidence, regulatory status, potential benefits, and risks can differ substantially between treatments. Patients should therefore ask about the specific therapy being considered rather than assuming that information about one regenerative treatment applies to another.
Why Consider Non-Surgical Options?
Surgery can be an appropriate treatment for certain medical conditions, but not every patient with joint or musculoskeletal symptoms requires surgery immediately.
Depending on the diagnosis, healthcare professionals may first consider established non-surgical approaches such as physical therapy, activity modification, medications when appropriate, or other conservative treatments.
Some patients may also ask about regenerative medicine during these discussions. Whether a particular regenerative treatment is reasonable to consider depends on the specific condition, available evidence, medical history, and treatment goals.
The purpose of considering non-surgical options is not necessarily to avoid surgery at all costs. Instead, the goal is to understand the available choices and determine which approach is medically appropriate for the individual.
What Should Be Evaluated Before Treatment?
Before considering regenerative medicine, an appropriate medical evaluation is important.
A healthcare professional may review:
- The location and duration of symptoms
- Medical history
- Previous injuries or treatments
- Physical examination findings
- Current medications and other relevant health information
- Imaging or diagnostic testing when appropriate
- Individual treatment goals
This information can help determine the possible causes of symptoms and whether additional treatment or evaluation may be appropriate.
Common Regenerative Medicine Approaches
Regenerative medicine includes a variety of approaches, and the evidence supporting them can differ.
Platelet-Rich Plasma (PRP)
PRP is prepared from a patient’s own blood by processing a blood sample to concentrate platelets. PRP has been studied for a variety of musculoskeletal conditions.
Research findings are not uniform across all conditions or treatment protocols. Factors such as the condition being treated, preparation methods, and treatment protocols can influence research outcomes.
Anyone considering PRP should discuss the specific treatment, available evidence, potential risks, and expected outcomes with a qualified healthcare professional.
Cell-Based Therapies
Cell-based therapies are another area of regenerative-medicine research. Different cell-based treatments may involve different sources, preparation methods, and regulatory considerations.
Because these treatments are not all the same, patients should ask specifically what product or procedure is being proposed, what it is intended to do, what evidence supports its use for their condition, and what its regulatory status is.
The FDA has cautioned consumers about regenerative-medicine products, including certain stem-cell and cell-based products, that are marketed for orthopedic and other conditions without appropriate FDA approval. Patients should be cautious about claims that a regenerative product is FDA-approved for a particular orthopedic condition when that approval has not been established.
What Does the Research Show?
Research into regenerative medicine is ongoing, and the amount and quality of evidence vary depending on the treatment and medical condition.
Some studies have reported improvements in certain outcomes for particular treatments and conditions, while other research has produced mixed or inconclusive findings.
This means that evidence from one study or one type of regenerative treatment should not automatically be interpreted as proof that every regenerative therapy will provide the same results.
Patients should also be cautious of claims based primarily on individual testimonials or isolated success stories. Personal experiences can be meaningful to the people involved, but they do not establish that a treatment will produce the same result for other patients.
The FTC recommends that health-related benefit claims be supported by competent and reliable scientific evidence and that marketers consider both express and implied claims communicated to consumers.
Regenerative Medicine and Surgery
Regenerative medicine and surgery are different approaches to healthcare.
Some regenerative treatments may be non-surgical or minimally invasive, while surgical procedures can involve repairing, removing, replacing, or otherwise modifying structures within the body.
It is important not to assume that one approach is automatically better than another. The appropriate treatment depends on the diagnosis, severity of the condition, overall health, previous treatment, and other individual circumstances.
For some patients, non-surgical treatment may be appropriate. For others, surgery or another established treatment may be recommended. A qualified healthcare professional can explain the potential benefits, limitations, risks, and alternatives.
Regenerative medicine should not be promoted as a guaranteed way to avoid surgery.
Questions to Ask Your Healthcare Professional
If you are considering regenerative medicine, having an informed conversation with your healthcare professional can help you understand your options.
Useful questions may include:
- What is causing my symptoms?
- What treatment options are appropriate for my condition?
- What specific regenerative treatment is being considered?
- What evidence supports this treatment for my particular condition?
- What are the potential benefits and risks?
- Are there established non-surgical treatments I should consider?
- Would surgery be appropriate for my condition?
- What outcomes are realistic?
- How would my progress be evaluated?
- What would be the next step if the treatment does not provide the expected result?
These questions can help patients make decisions based on their individual circumstances rather than generalized claims about regenerative medicine.
When Should You Seek Medical Evaluation?
Persistent or worsening joint and musculoskeletal symptoms should be evaluated by an appropriate healthcare professional.
An evaluation can help identify the potential cause of symptoms and determine whether conservative care, regenerative medicine, surgery, or another approach should be considered.
People experiencing severe symptoms, significant loss of function, or symptoms following a serious injury should seek appropriate medical attention rather than delaying evaluation while researching treatment options.
Realistic Expectations Are Important
Regenerative medicine continues to be an area of research and clinical interest, but results are not guaranteed.
The potential benefits and limitations depend on the specific treatment, the condition being addressed, the available evidence, and individual patient factors.
Patients should be cautious about claims promising permanent pain relief, complete tissue regeneration, guaranteed healing, elimination of surgery, or a specific success rate without strong evidence supporting the particular claim.
A qualified healthcare professional can help explain what is known about a treatment, what remains uncertain, and which alternatives may be appropriate.
Conclusion
Considering regenerative medicine before surgery does not mean that surgery should always be avoided or delayed. Instead, it can be part of a broader conversation about treatment options when a patient is exploring non-surgical approaches to a musculoskeletal condition.
The suitability of regenerative medicine depends on the individual’s diagnosis, medical history, treatment goals, and the specific therapy being considered. Research and evidence vary between treatments, and outcomes cannot be guaranteed.
A thorough medical evaluation and an open discussion with a qualified healthcare professional can help patients understand their options, potential risks, available evidence, and realistic expectations before making a treatment decision.